Lucid Diagnostics Inc.

NASDAQ:LUCD

1.1 (USD) • At close July 1, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Revenue 4.3462.4280.3770.5000
Cost of Revenue 7.0998.4783.6140.585000
Gross Profit -3.92-6.05-3.237-0.085000
Gross Profit Ratio -0.902-2.492-8.586-0.17000
Reseach & Development Expenses 5.9927.25211.4669.2965.4433.4620.716
General & Administrative Expenses 20.15619.25423.97412.7782.8370.9590.615
Selling & Marketing Expenses 16.46316.40416.1345.261.30500
SG&A 36.1435.1839.81918.0382.8370.9590.41
Other Expenses 0.688-0.47800000
Operating Expenses 42.13242.43252.93427.3348.284.4211.126
Operating Income -46.052-48.482-56.171-27.419-8.28-4.421-1.126
Operating Income Ratio -10.596-19.968-148.995-54.838000
Total Other Income Expenses Net 0.523-4.1840.08-0.659000
Income Before Tax -45.529-52.666-56.171-28.078-8.28-4.421-1.126
Income Before Tax Ratio -10.476-21.691-148.995-56.156000
Income Tax Expense 7,49601.7080.659-8.28-4.421-1.689
Net Income -45.529-52.666-56.171-28.078-8.28-4.421-1.126
Net Income Ratio -10.476-21.691-148.995-56.156000
EPS -1.05-1.26-1.55-1.51-0.22-0.12-0.03
EPS Diluted -1.05-1.26-1.55-1.51-0.22-0.12-0.03
EBITDA -44.336-49.751-54.235-27.415000.563
EBITDA Ratio -10.202-20.491-143.859-54.83000